Vanda Pharmaceuticals Inc - Articles and news items

Phase III results for Vanda’s Hetlioz published in The Lancet

Industry news / 5 August 2015 / Victoria White

Pivotal trial results from Phase III studies of Vanda Pharmaceuticals’ Hetlioz® (tasimelteon) have been published in The Lancet…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+